Blauvelt A, Warren R, Reich K, Brock F, Fierens F, Ciaravino V, Lebwohl M. Durability of DLQI Improvements Among Patients with Moderate to Severe Plaque Psoriasis Treated with Certolizumab Pegol: Three-Year Results from Two Phase 3 Trials (CIMPASI-1 and CIMPASI-2). J of Skin [Internet]. 2020Oct.27 [cited 2024Sep.20];4(6):s80. Available from: https://dermsquared.com/skin/article/view/1113